Test: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
|colspan="1" style = "font-size:80%; width: 80%; |'''Comment''' | |colspan="1" style = "font-size:80%; width: 80%; |'''Comment''' | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |CD19 | ||
|colspan="1" style = "background:#006699;"| | |colspan="1" style = "background:#006699;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"| | ||
|- | |- | ||
|colspan="1" style = "width: 4%; font-size:90%; color:black;" | | |colspan="1" style = "width: 4%; font-size:90%; color:black;" |κ/λ | ||
|colspan="1" style = "width: 8%; background:#006699;"| | |colspan="1" style = "width: 8%; background:#006699;"| | ||
|colspan="1" style = "font-size:80%; width: 8%; | | |colspan="1" style = "font-size:80%; width: 8%; | | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"|- | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |CD5 | ||
|colspan="1" style = "background:# | |colspan="1" style = "background:#66e0ff;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:80%;"|Characteristic of CLL, usually less strong than on T cells | |colspan="1" style = "font-size:80%;"|Characteristic of CLL, usually less strong than on T cells |
Revision as of 13:02, 12 July 2023
Background to flow cytometric diagnosis
This is an uncommon diagnosis by flow cytometry as DLBCL cells generally circulate and involve bone marrow only at only a late stage in disease (ofetn when a diagnosis has already been made). However, occasionally these cases can present as a new diagnosis by blood or marrow and can be difficult as marker expression is often variable between cases.
Immunophenotype of CLL | |||
---|---|---|---|
Major markers useful in CLL diagnosis | |||
Marker | Freq | Level | Comment |
CD19 | - | ||
κ/λ | - | ||
CD5 | - | Characteristic of CLL, usually less strong than on T cells | |
CD23 | - | Characteristic of CLL, although can rarely be weak or absent | |
CD79b | wk | Expression is expected, but characteristically weak | |
CD200 | - | Characteristically positive in CLL and negative in MCL | |
FMC7 | May be expressed by atypical cases, generally absent | ||
Other relevant markers | |||
CD10 | - | ||
CD11C | - | ||
CD20 | - | ||
CD25 | - | ||
CD38 | - | ||
CD43 | - | ||
CD103 | - | ||
CD138 | - |
Key to table:
Key to colour code for expression frequency Click for link
Key to expression strength code and use Click for link